SVB Capital

John China, President of SVB Capital, oversees the platform's investment strategy and final approvals. China joined the firm in 2012 after previously heading the bank's technology and life sciences commercial banking groups, giving him both operating and underwriting experience. Each strategy vertical — funds of funds, direct venture, venture debt, and secondaries — maintains its own investment committee with dedicated sector specialists.

SVB Capital operated inside Silicon Valley Bank, which held banking relationships with roughly half of all US venture-backed technology and life sciences companies. The commercial banking teams saw cash balances, burn rates, and funding rounds across thousands of startups, creating an early-warning system that flagged high-performing companies months before they formally raised capital. This proprietary flow gave SVB Capital's investment teams a first-look advantage that no independent venture firm could replicate.

The FDIC placed SVB Financial Group into receivership but explicitly excluded SVB Capital's fund entities, which were separate legal structures. SVB Capital continued managing its existing portfolio companies and fund commitments without interruption. Fundraising for new vehicles paused as the platform's future ownership was resolved. Multiple parties expressed interest in acquiring the platform, but the outcome remained unresolved through late 2024.

SVB Capital operates both a funds-of-funds program and a direct investment practice. The funds-of-funds team historically backed managers including Accel, Sequoia Capital, and Founders Fund. The direct team pursues seed through late-stage equity rounds. The platform also runs a venture debt strategy providing non-dilutive loans and a secondaries desk targeting LP portfolios and structured credit in innovation sectors.

The platform operates from six offices: Santa Clara, San Francisco, Menlo Park, Boston, New York, and London. It also maintained presence in Shanghai through the parent bank's broader Asian operations. Portfolio exposure spans North America, Europe, and select Asian markets, with the heaviest concentration in US-based enterprise software, fintech, and digital health companies.